| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 4e-07 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |